Rare lephants

Screener

Silence Therapeutics plc

SLN ·Healthcare, Drug Manufacturers - General

Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation

EPS
Sales Per Share
Book Per Share
FCF Per Share
Dividend Per Share
Shares Outstanding

Share-Based Metrics › Shares Outstanding

← 5Y 10Y MAX →

Shares Outstanding

Fiscal Year	Shares Outstanding
FY2022	96.6M
FY2023	111.3M
FY2024	138.8M
FY2025	141.7M
FY2026	141.7M

About Contact Terms Privacy